<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BU Now &#187; personalized medicine</title>
	<atom:link href="http://blogs.bu.edu/bunow/tag/personalized-medicine/feed/" rel="self" type="application/rss+xml" />
	<link>http://blogs.bu.edu/bunow</link>
	<description>News, information and research from Boston University</description>
	<lastBuildDate>Wed, 21 Sep 2011 18:14:24 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.4</generator>
		<item>
		<title>A big step towards personalized medicine</title>
		<link>http://blogs.bu.edu/bunow/2009/08/28/a-big-step-towards-personalized-medicine/</link>
		<comments>http://blogs.bu.edu/bunow/2009/08/28/a-big-step-towards-personalized-medicine/#comments</comments>
		<pubDate>Fri, 28 Aug 2009 13:54:08 +0000</pubDate>
		<dc:creator>Ron Rosenberg</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[non-small cell lung cancer]]></category>
		<category><![CDATA[personalized medicine]]></category>

		<guid isPermaLink="false">http://blogs.bu.edu/bunow/?p=2991</guid>
		<description><![CDATA[An agreement  in which Abbott Laboratories will develop a specific genetic test to screen non-small cell lung cancer tumors to identify potential patients for a proposed oral cancer drug  being developed by Pfizer, was hailed as an important development in the new era of personalized genomic medicine, by Avi Spira, MD.  He is Associate Professor of [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.reuters.com/article/rbssHealthcareNews/idUSN2744434020090827" target="_blank">An agreement</a>  in which Abbott Laboratories will develop a specific genetic test to screen non-small cell lung cancer tumors to identify potential patients for a proposed oral cancer drug  being developed by Pfizer, was hailed as an important development in the new era of personalized genomic medicine, by <a href="http://www.bumc.bu.edu/pulmonary/people/avrumspira/" target="_blank">Avi Spira, MD. </a> He is Associate Professor of Pathology andLaboratory Medicine.</p>
<p><em>&#8220;This is a very big step if they can first identify the subset that will benefit prior to treatment.&#8221;</em> </p>
<p>Contact Avi Spria, 617-414-6980, <a href="mailto:aspira@bu.edu">aspira@bu.edu</a></p>
]]></content:encoded>
			<wfw:commentRss>http://blogs.bu.edu/bunow/2009/08/28/a-big-step-towards-personalized-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
